The effect of clinical pathways utilization on total cost of care for the treatment of prostate cancer

Autor: Jason M Burkett, David Boulware, Karen K. Fields, Vasanth Kailasam, Karen A Sereday, Dana E. Rollison, Diane L. Blazevich, Julio M. Pow-Sang, JuQing Shi, Sandra C. Stewart, Peter A S Johnstone
Rok vydání: 2019
Předmět:
Zdroj: Journal of Clinical Oncology. 37:20-20
ISSN: 1527-7755
0732-183X
DOI: 10.1200/jco.2019.37.27_suppl.20
Popis: 20 Background: Moffitt Cancer Center (MCC) has developed evidence-based cancer care pathways which are integrated into the Electronic Health Record (EHR). We retrospectively compared the 1 year (yr) total cost of care in patients (pts) with newly diagnosed prostate cancer (PCA) treated at MCC based on EHR tool utilization and pathway alignment. Methods: Using existing Cancer Registry data, we retrospectively identified all pts presenting with newly diagnosed PCA between 7/1/2015-6/30/2017 who received all 1st course treatment (tx) at MCC. Pts direct costs were tracked for 1 yr from the Cancer Registry “date of 1st contact.” Tx was categorized as either radiation (RT) +/- hormone tx (HT), surgery (S) +/- HT, active surveillance only (ASO), HT only, palliative care, chemotherapy (CT), or mixed (a combination of S, RT, or CT). Pathway alignment was either electronically tracked through the EHR pathway tool or determined through manual chart review for pts tx’ed off the pathway tool. Results: 477 pts met inclusion criteria, including men with: low or favorable intermediate (n=259); unfavorable intermediate, high, or very high (n=186); and metastatic (n=32) risk group PCA. The majority (n=396, 83%) had tx in alignment with a pathway. The major tx modalities on pathway were S-HT (n=139), RT-HT (n=113), or ASO (n=110) and off pathway were RT-HT (n=52, 64%), S-HT (n=10), or ASO (n=9). Overall, treatment in alignment with a pathway was significantly associated with lower 1 yr total cost compared to off pathway tx (p
Databáze: OpenAIRE
Externí odkaz: